Phagocytic properties of microglia in vitro: Implications for a role in multiple sclerosis and EAE

Microscopy Research and Technique

Volumn 54, Issue 2, 2001, Pages 81-94

  Smith, Marion E ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; MACROPHAGES; TISSUE CULTURE;

ACTIVATING PROCESS; CENTRAL NERVOUS SYSTEMS; CLASS I; IN-VITRO; MICROGLIA; MICROGLIAL CELLS; MULTIPLE SCLEROSIS; PHAGOCYTIC CELLS; PHAGOCYTOSE; PROPERTY;

MOLECULES;

ALPHA 2 MACROGLOBULIN; CELL ADHESION MOLECULE; COMPLEMENT RECEPTOR; CYTOKINE; FC RECEPTOR; GALECTIN 3; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN RECEPTOR; MANNOSE RECEPTOR; MYELIN; SCAVENGER RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; ASTROCYTE; CELL ACTIVATION; DEMYELINATING DISEASE; DISEASE ASSOCIATION; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NEWBORN; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

EID: 0035879567     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.1123     Document Type: Article

References (126)

1. Aloisi F, DeSimone R, Columba-Cabezas S, Penna G, Adorini L. 2000. Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor with Th1 cells. J Immunol 164:1705-1712.
2. Archelos JJ, Storch MK, Hartung H-P. 2000. The role of B cells and autoantibodies in multiple sclerosis. Ann Neurol 47:694-706.
3. Ashwell, K. 1990. Microglia and cell death in the developing mouse cerebellum. Dev Brain Res 55:219-230.
4. Baker D, O'Neill JK, Turk JL. 1991. Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. Cell Immunol 134:505-510.
5. Bell MD, Lopez-Gonzalez R, Lawson L, Hughes D, Fraser I, Gordon S, Perry VH. 1994. Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS. J Neurocytol 23:605-616.
6. Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 161:3299-3306.
7. Bo L, Mork S, Kong PA, Nyland H, Pardo CA, Trapp BD. 1994. Detection of MHC Class II antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 51:135-146.
8. Bronstein JM, Lallone RL, Seitz RS, Ellison GW, Myers LW. 1999. A humoral response to oligodendrocyte-specific protein in MS. Neurology 53:154-161.
9. Brosnan CF, Bornstein MB, Bloom BR. 1981. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol 126:614-620.
10. Bu G, Maksymovitch EA, Nerbonne JM, Schwartz AL. 1994. Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J Biol Chem 269: 18521-18528.
11. Cannella B, Raine CS. 1995. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 37:424-435.
12. Cannella B, Gao YL, Brosnan C, Raine CS. 1996. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J Neurosci Res 45:735-746.
13. Chamak B, Mallat M. 1991. Fibronectin and laminin regulate the in vitro differentiation of microglial cells. Neuroscience 45:513-527.
14. Compston DAS, Morgan BP, Campbell AK, Wilkins P, Cole G, Thomas ND, Jasani B. 1989. Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol Appl Neurobiol 15:30316.
15. Czapiga, RI, Colton CA. 1999. Function of microglia in organotypic slice cultures. J Neurosci Res 56:644-651.
16. Davoust N, Nataf S, Reiman R, Holers MV, Campbell IL, Barnum SR. 1999. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis. J Immunol 163:6551-6556.
17. Day ED, Pitts OM. 1974. The antibody response to myelin basic protein (MBP) in Lewis rats: The effect of time, dosage of BP, and dosage of mycobacterium butyricum. J Immunol 113:1958-1967.
18. DeJong B, Smith, ME. 1997. A role for complement in phagocytosis of myelin. Neurochem Res 22:491-498.
19. Del Rio-Hortega, P. 1932. Microglia. In: Penfield W, editor. Cytology and cellular pathology of the nervous system, Vol 2. New York: Paul B Hoeber. p 483-534.
20. Epstein LG, Prineas JW, Raine CS. 1983. Attachment of myelin to coated pits on macrophages in experimental allergic encephalomyelitis. J Neurol Sci 61:341-348.
21. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. 1992. Exposure of phosphatidyl serine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207-2216.
22. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A. 1987. Antigen presentation and tumor toxicity by interferon-γ-treated microglial cells. Eur J Immunol 17:1271-1278.
23. Fujita S, Kitamura T. 1975. Origin of brain macrophages and the nature of the so-called microglia. Acta Neuropathol Suppl VI:291-296.
24. Gebicke-Haerter PJ, Bauer J, Schobert A, Northoff, H. 1989. Lipopolysaccharide-free conditions in primary astrocyte cultures allow growth and isolation of microglial cells. J Neurosci 9:183-194.
25. Gehrmann J, Gold R, Linington C, Lannes-Vieira J, Wekerle H, Kreutzberg GW. 1992. Spinal cord microglia in experimental allergic neuritis. Evidence for fast and remote activation. Lab Invest 67:100-113.
26. Genain CP, Cannella B, Hauser SL, Raine CS. 1999. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med 5:170-175.
27. Giulian D. 1987. Ameboid microglia as effectors of inflammation in the central nervous system. J Neurosci Res 18:155-171.
28. Giulian D, Baker TJ. 1986. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 6:2163-2178.
29. Giulian D, Ingeman JE. 1988. Colony-stimulating factors as promotors of ameboid microglia. J Neurosci 8:4707-4717.
30. Giulian D, Li J, Leara B, Keenen C. 1994. Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture. Neurochem Int 25:227-233.
31. Goldstein JL, Anderson RGW, Brown MS. 1979. Coated pits, coated vesicles and receptor-mediated endocytosis. Nature 279:679-685.
32. Gonatas NK, Gonatas JO, Strieber A, Lisak R, Suzuki K, Martenson RE. 1974. The significance of circulating and cell-bound antibodies in experimental allergic encephalomyelitis. 1974. Am J Pathol 76: 529-546
33. Graeber MB, Streit, Kreutzberg GW. 1988. Axotomy of the rat facial nerve leads to increased increased CR3 complement receptor expression by activated microglial cell. J Neurosci Res 21:18-24.
34. Graeber MB, Banati RB, Streit WJ, Kreutzberg GW. 1989. Immunophenotypic characterization of rat brain macrophages in culture. Neurosci Lett 103:241-246.
35. Hayes GM, Woodroofe MN, Cuzner ML. 1987. Microglia are the major cell type expressing MHC Class II in human white matter. J Neurol Sci 80:25-37.
36. Hayes GM, Woodroofe MN, Cuzner ML. 1988. Characterization of microglia isolated from adult human and rat brain. J Neuroimmunol 19:177-189.
37. Hickey WF, Kimura H. 1988. Perivascular microglial cells of the CNS are bone-marrow derived and present antigen in vivo. Science 239: 290-292.
38. Huitinga I, van Rooijen N, de Groot CJA, Uitdehaag MBJ, Dyjkstra CD. 1990. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 172: 1025-1037.
39. Konno H, Yamamoto T, Iwasaki Y, Saitoh T, Suzuki H, Terunuma H. 1989. Ia-expressing microglial cells in experimental allergic encephalomyelitis in rats. Acta Neuropathol 77:472-479.
40. Korner H, Lemckert FA, Chaudhri G, Etteldorf S, Sedgwick JD. 1997. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system. Eur J Immunol 27:1973-1981.
41. Krieger M, Herz J. 1994. Structure and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein (LRP). Ann Rev Biochem 63:601-637.
42. Kuroda Y, Shimamoto Y. 1991. Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in rats. J Neuroimmunol 34:159-164.
43. Kuruvilla AP, Shah R, Hochwald GM, Liggett HD, Palladino MA, Thorbecke GJ. 1991. Protective effect of transforming growth factor β on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 88:2819-2821.
44. Kuwert E, Niedieck B. 1965. Anticerebroside antibodies in cerebrospinal fluid of rabbits with experimental allergic encephalomyelitis. Nature 207:991-992
45. Ledeboer A, Breve JJP, Poole S, Tilders FJH, Van Dam A-M. 2000. Interleukin 10, inter- leukin-4, and transforming growth factor-β differentiatially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglia and microglial cells. Glia 30:134-142.
46. Lee SC, Liu W, Brosnan CF, Dickson DW. 1992. Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia. Lab Invest 67:465-476.
47. Lee SC, Liu W, Brosnan CF, Dickson DW. 1994. GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. Glia 12:309-318.
48. Legge KL, Min B, Bell J, Caprio JC, Li L, Gregg RK, Zaghouani H. 2000. Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis. J Exp Med 191:2039-2051.
49. Li H, Cuzner ML, Newcombe J. 1996. Microglia-derived macrophages in early multiple sclerosis plaques. Neuropathol Appl Neurobiol 22:207-215.
50. Lieberman AP, Pitha PM, Shin HS, Shin ML. 1989. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 86:6348-6352.
51. Liesi P, Dahl D, Vaheri A. 1983. Laminin is produced by early rat astrocytes in primary culture. J Cell Biol 96:920-929.
52. Ling EA, Kauer C, Wong WC. 1982. Light and electron microscopic demonstration of non-specific esterase in ameboid microglial cells in the corpus callosum in postnatal rats: a cytochemical link to monocytes. J Anat 135:385-394.
53. Linington C, Morgan BP, Scolding NJ, Wilkins P, Piddlesden S, Compston DAS. 1989. The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 112:895-911.
54. Link H. 1998. The cytokine storm in multiple sclerosis. Multiple Sclerosis 4:12-15.
55. Link H, Baig S, Olsson O, Yu-Ping J, Hojeberg B, Olsson T. 1990. Persistent anti-myelin basic protein IgG antibody response in multiple sclerosis cerebrospinal fluid. J Neuroimmunol 28:237-248.
56. Malipiero UV, Frei K, Fontana A. 1990. Production of hemopoietic colony-stimulating factors by astrocytes. J Immunol 144:3816-3821.
57. Martiney JA, Rajan AJ, Charles PC, Cerami A, Ulrich PC, MacPhail S, Tracey KJ, Brosnan CF. 1998. Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage deactivating agent. J Immunol 160:5588-5595.
58. Marzolo MP, von Bernhardi R, Inestrosa NC. 1999. Mannose receptor is present in a functional state in rat microglial cells. J Neurosci Res 58:387-395.
59. Marzolo MP, von Bernhardi R, Bu G, Inestrosa NC. 2000. Expression of α-2 macroglobulin receptor/low density lipoprotein receptor-related protein (LRP) in rat microglial cells. J Neurosci Res 60:401-411.
60. Matsumoto Y, Ohmori K, Fujiwara M. 1992. Immune regulation by brain cells in the central nervous system: miroglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions. Immunology 76:209-216.
61. Matyszak MK, Denis-Donini S, Citterio S, Longhi R, Granucci F, Ricciardi-Castagnoli P. 1999. Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activation. Eur J Immunol 29:3063-3076.
62. Mehta PD, Patrick BA, Mehta SP, Wisniewski HM. 1987. Specificity of oligoclonal IgG bands against myelin proteins in chronic relapsing EAE in guinea pigs. J Immunol 138:746-751.
63. Morioka T, Streit WJ. 1991. Expression of immunomolecules on microglial cells following neonatal sciatic nerve axotomy. J Neuroimmunol 35:21-30.
64. Mosley K, Cuzner ML. 1996. Receptor-mediated phagocytosis of myelin by macrophages and microglia. Effect of opsonization and receptor blocking agents. Neurochem Res 21:481-487.
65. Mukhopadhyay G, Doherty P, Walsh FS, Crocker PR, Filbin MT. 1994. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 13:757-767.
66. Naito M, Kodama T, Matsumoto A, Doi T, Takahashi K. 1991. Tissue distribution, intracellular localization, and in vitro expression of bovine macrophage scavenger receptors. Am J Pathol 139:1411-1423.
67. Newman SL, Tucci MA. 1990. Regulation of human monocyte/macrophage function by extracellular matrix. Adherence of monocytes to collagen matrices enhances phagocytosis of opsonized bacteria by activation of complement receptors and enhancement of Fc receptor function. J Clin Invest 86:703-714.
68. Norton WT, Cammer W. 1984. Chemical pathology of diseases involving myelin. In: Morell P, editor. Myelin. New York: Plenum Press, p 369-403.
69. Nyland H, Matre R, Mork S. 1980. Fc receptors on microglial lipophages in multiple sclerosis. New Eng J Med 302:120-121.
70. Olsson T. 1995. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev 144:245-268.
71. Panek RB, Benveniste EN. 1995. Class II MHC gene expression in microglia. Regulation by the cytokines IFN-γ, TNF-α and TGF-β. J Immunol 154:2846-2854.
72. Panitch HS, Hirsch RL, Schindler J, Johnson KP. 1987. Treatment of multiple sclerosis with gamma interferon. Exacerbations associated with activation of the immune system. Neurology 37:1097-1102.
73. Perry VH, Gordon S. 1988. Macrophages and microglia in the nervous system. TINS 11:273-277
74. Pesheva P, Urschel S, Frei K, Probstmeier R. 1998. Murine microglial cells express functionally active galectin-3 in vitro. J Neurosci Res 51:49-57.
75. Prabhakar S, Kurien E, Gupta RS, Zielinski S, Freedman MS. 1994. Heat shock protein immunoreactivity in CSF. Correlation with oligoclonal banding and demyelinating disease. Neurology 44: 1644-1648.
76. Price J, Hynes RO. 1985. Astrocytes in culture synthesize and secrete a variant form of fibronectin. J Neurosci 5:2205-2211.
77. Prineas JW, Connell F. 1978. The fine structure of chronically active multiple sclerosis plaques. Neurology 28:68-75.
78. Prineas JW, Graham JS. 1981. Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown. Ann Neurol 10:149-158.
79. Racke MK, Dhib-Jalbut S, Canella B, Albert PS, Raine CS, McFarlin DE. 1991. Prevention and treatment of chronic relapsing allergic encephalomyelitis by transforming growth factor-β. J Immunol 146: 3012-3017.
80. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, Shevach EM, Rocken M. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180:1961-1966.
81. Raine CS. 1985. Demyelinating diseases. In: Davis RI, Robertson DM, editors. Textbook of neuropathology. Baltimore: Williams and Wilkins. p 468-547.
82. Rebeck GW, Harr SD, Strickland DK, Hyman BT. 1995. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the α2-macroglobulin receptor/low-density lipoprotein receptor-related protein. Ann Neurol 37:211-217.
83. Ren Y, Silverstein RL, Allen J, Savill J. 1995. CD36 gene transfer confers capacity for phagocyosis of cells undergoing apoptosis. J Exp Med 181:1857-1862.
84. Reichert F, Rotshenker S. 1996. Deficient activation of microglia during optic nerve degeneration. J Neuroimmmunol 70:153-161.
85. Reichert F, Rotshenker S. 1999. Galectin3/MAC-2 in experimental allergic encephalomyelitis. Exp Neurol 160:508-514.
86. Rieske E, Graeber MB, Tetzlaff W, Czlonkowska A, Streit WJ, Kreutzberg GW. 1989. Microglia and microglia-derived brain macrophages in culture: generation from axotomized rat facial nuclei, identification, and characterization in vitro. Brain Res 492:1-14.
87. Rigotti A, Acton SL, Krieger M. 1995. The class B scavenger receptors SR-B1 and CD36 are receptors for anionic phospholipids. J Biol Chem 270:16221-16224.
88. Rinner WA, Bauer J, Schmidts M, Lassmann H, Hickey WF. 1995. Resident microglia and hematogenous macrophages as phagocytes in adoptively transferred experimental autoimmune encephalomyelitis: an investigation using rat radiation bone marrow chimeras. Glia 14:257-266.
89. Rott O, Fleischer B, Cash E. 1994. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 24:1434-1440.
90. Saada A, Reichert F, Rotshenker S. 1996. Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells. J Cell Biol 133:159-167.
91. Sadler RH, Sommer MA, Forno LS, Smith ME. 1991. Induction of anti-myelin antibodies and their possible role in demyelination. J Neurosci Res 30:616-624.
92. Sambrano GR, Steinberg D. 1995. Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages. Role of membrane phosphatidylserine. Proc Natl Acad Sci USA 92:1396-1400.
93. Schwab ME. 1990. Myelin-associated inhibitors of neurite growth and regeneration in the CNS. TINS 13:452-456.
94. Scolding NJ, Zajicek JP, Wood N, Compston DAS. 1994. The pathogenesis of demyelinating disease. Progr Neurobiol 43:143-173.
95. Sedgwick JD, Schwender S, Gregersen R, Corries R, ter Meulen V. 1993. Resident macrophages (ramified microglia) of the adult Brown Norway rat central nervous system are constitutively major histocompatibility complex Class II positive. J Exp Med 177:1145-1152.
96. Sellebjerg FT, Frederiksen JL, Olsson T. 1994. Anti-myelin basic protein and anti-proteolipid protein antibody secreting cells in the cerebrospinal fluid of patients with acute optic neuritis. Arch Neurol 51:1032-1036.
97. Sellebjerg F, Jaliashvili I, Christiansen M, Garred P. 1998. Intrathecal activation of the complement system and disability in MS. J Neurol Sci 157:168-174.
98. Shah SN, Johnson RC. 1980. Activity levels of cholesterol ester metabolizing enzymes in brain in multiple sclerosis: correlation with cholesterol ester concentrations. Exp Neurol 68:601-604.
99. Sievers J, Parwaresch R, Wottge H-U. 1994. Blood monocytes and spleen macrophages differentiate into microglia-like cells on monolayers of astrocytes. Morphology. Glia 12:245-258.
100. Smith Begolka W, Miller SD. 1998. Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental allergic encephalomyelitis. Res Immunol 149:771-781.
101. Smith ME. 1993. Phagocytosis of myelin by microglia in vitro. J Neurosci Res 35:480-487.
102. Smith ME. 1999. Phagocytosis of myelin in demyelinative disease: a review. Neurochem Res 24:261-268.
103. Smith ME, Hoerner MT. 2000. Astrocytes modulate macrophage phagocytosis of myelin in vitro. J Neuroimmunol 154:154-162.
104. Smith ME, van der Maesen K, Somera FP. 1998. Macrophage and microglial responses to cytokines in vitro. Phagocytic activity, proteolytic enzyme release and free radical production. J Neurosci Res 54:68-78.
105. Sommer MA, Forno LS, Smith ME. 1992. EAE cerebrospinal fluid augments in vitro phagocytosis and metabolism of CNS myelin by macrophages. J Neurosci Res 32:384-394.
106. Streit WJ, Kreutzberg GW. 1988. Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin. J Comp Neurol 268:248-263.
107. Streit WJ, Walter SA, Pennell NA. 1999. Reactive gliosis. Prog in Neurobiol 57: 563-581.
108. Suzumura A, Mezitis SGE, Gonatas NK, Silberberg DH. 1987. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by γ-interferon. J Neuroimmunol 15:263-278.
109. Suzumura A, Sawada M, Yamamoto H, Marunouchi T. 1990. Effects of colony stimulating factors on isolated microglia in vitro. J Neuroimmunol 30:111-120
110. Tabira T, Endoh M. 1985. Humoral immune responses to myelin basic protein, cerebroside, and ganglioside in chronic relapsing experimental allergic encephalomyelitis of the guinea pig. J Neurol Sci 67:201-212.
111. Thomas WE. 1992. Brain macrophages: evaluation of microglia and their functions. Brain Res Revs 17:61-74.
112. Toku K, Tanaka J, Fujikata S, Hamamoto Y, Horikawa Y, Miyoshi K, Tateishi N, Suzuki Y, Maeda N. 1999. Distinctions between microglial cells and peripheral macrophages with regard to adhesive activities and morphology. J Neurosci Res 57:855-865.
113. Torvik A. 1975. The relationship between microglia and brain macrophages. Experimental investigations. Acta Neuropathol Suppl VI: 297-300.
114. Tran EH, Hoekstra K, van Rooijen N, Dyjkstra CD, Owens T. 1998. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood are prevented in macrophage-depleted mice. J Immunol 161:3767-3775.
115. Trotter J, DeJong LJ, Smith ME. 1986. Opsonization with antimyelin antibody increases the uptake and intracellular metabolism of myelin in inflammatory macrophages. J Neurochem 47:779-789.
116. Ulvestad E, Williams K, Matre R, Nyland H, Olivier A, Antel J. 1994. Fc receptors for IgG on cultures of human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets. J Neuropathol Exp Neurol 53:27-36.
117. Vanguri P, Koski CL, Silverman B, Shin ML. 1982. Complement activation by isolated myelin: Activation of the classical pathway in the absence of myelin-specific antibodies. Proc Natl Acad Sci USA 79:3290-3294.
118. Werb Z. 1997. ECM and cell surface proteolysis: Regulating cellular ecology. Cell 91:439-442.
119. Willenborg DO, Fordham SA, Cowden WB, Ramshaw IA. 1995. Cytokine and murine autoimmune encephalomyelitis: Inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand J Immunol 41:31-41.
120. Williams K, Bar-Or A, Ulvestad E, Olivier A, Antel JP, Yong VW. 1992. Biology of adult human microglia in culture: Comparisons with peripheral blood monocytes and astrocytes. J Neuropath Exp Neurol 51:538-549.
121. Wolf BB, Lopes MBS, VandenBerg SR, Gonias SL. 1992. Characterization and immunohistochemical localization of α2-macroglobulin receptor (low density lipoprotein receptor-related protein) in human brain. Am J Pathol 141:37-42.
122. Xiao B-G, Linington C, Link H. 1991. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J Neuroimmunol 31:91-96.
123. Yagi R, Tanaka S, Koike T. 1999. Thapsigargin induces microglial transformation from ameboid to ramified type in vitro. Glia 28:49-52.
124. Young DA, Lowe LD, Booth SS, Whitters MJ, Nicholson L, Kuchroo VK, Collins M. 2000. IL-4, IL-10, IL-13, and TGF-β from an altered peptide ligand-specific TH2 cell clone down-regulates adoptive transfer of experimental autoimmune encephalomyelitis. J Immunol 164:3563-3572.
125. Yu RK, Ueno K, Glaser GH, Tourtellotte WW. 1982. Lipid and protein alterations of spinal cord and cord myelin of multiple sclerosis. J Neurochem 39:464-477.
126. Zachau AC, Strigard K, Baig S, Hojeberg B, Olsson T. 1989. Distribution of plasma cells secreting antibodies against nervous tissue antigens during experimental allergic encephalomyelitis enumerated by a nitrocellulose immunospot assay. J Neurol Sci 91:323-336.